All Stories

  1. Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
  2. CME-Labor 52
  3. CME-Labor 52/Auflösung
  4. Evaluation of the new restandardized Abbott Architect 25-OH Vitamin D assay in vitamin D-insufficient and vitamin D-supplemented individuals
  5. Pitfalls of LSD screening assays: comparison of KIMS and CEDIA immunoassays with LC-MS
  6. Impact of a single oral dose of 100,000 IU vitamin D3 on profiles of serum 25(OH)D3 and its metabolites 24,25(OH)2D3, 3-epi-25(OH)D3, and 1,25(OH)2D3 in adults with vitamin D insufficiency
  7. Effect of Twice-Yearly Denosumab on Prevention of Bone Mineral Density Loss inDe NovoKidney Transplant Recipients: A Randomized Controlled Trial
  8. Analytical and clinical performance of the new Fujirebio 25-OH vitamin D assay, a comparison with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and three other automated assays
  9. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay
  10. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement